UnitedHealth Group said it incurred $2.2 billion in direct response costs related to the Change Healthcare cyberattack for the year ended December 31, 2024. The company said Optum Insight experienced estimated business disruption impacts of $867 million.

1. 01

   UnitedHealth Group said it incurred $2.2 billion in direct response costs related to the Change Healthcare cyberattack for the year ended December 31, 2024. The company said Optum Insight experienced estimated business disruption impacts of $867 million.

2. 02

   UnitedHealth Group said it recorded a loss of $7.1 billion related to the sale of its Brazil operations in 2024, of which $4.1 billion reflected the impact of cumulative foreign currency translation losses. The company said its remaining South American operations were classified as held for sale and recorded a loss of $1.2 billion, of which $855 million related to the impact of cumulative foreign currency translation losses.

3. 03

   UnitedHealth Group said consolidated revenues for 2024 increased 8% compared to the prior year and earnings from operations were $32.3 billion compared to $32.4 billion last year. The company said diluted earnings per share were $15.51, impacted by the loss on sale of subsidiary and subsidiaries held for sale.

4. 04

   UnitedHealth Group said its cash, cash equivalents, available-for-sale debt securities and equity securities balances as of December 31, 2024 were $77.1 billion. The company said its Board of Directors increased the annual dividend rate to $8.40 per share in June 2024, compared to $7.52 per share, and as of December 31 had Board authorization to repurchase up to 33 million shares of common stock.

Key figures

Fiscal year ended December 31, 2024

Revenue

$400.3B

Operating income

$32.3B

Net income

$14.4B

EPS

$15.51

Operating cash flow

$24.2B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.